Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial

Not Applicable

Completed

• Conditions: Knee Arthroplasty

• Registration Number: NCT01003080
• Lead Sponsor: Montefiore Medical Center

Brief Summary

The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08
• Study First Submitted: 2009-10-27
• Study First Submitted QC: 2009-10-27
• Study First Posted: 2009-10-28
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Results First Submitted: 2010-11-19
• Results First Submitted QC: 2011-03-04
• Results First Posted: 2011-04-07
• Status Verified: 2018-08
• Last Update Submitted: 2018-08-21
• Last Update Posted: 2018-09-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

• Patient indicated for total knee arthroplasty

Exclusion Criteria

• Patients undergoing revision total knee arthroplasty
• Patients with blood disorders
• Patients on chronic anti-thrombotic medication such as Coumadin
• Patients with a history of deep vein thrombosis
• Patients with a history of pulmonary embolism

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Drain Output.	First 24 hours following surgery.	This is a measure of the average drain output collected in the first 24 hours following surgery.

Trial Locations

Locations (2)

Jack D. Weiler Hospital-Division of Montefiore Medical Center; 🇺🇸 Bronx, New York, United States

Montefiore Medical Center; 🇺🇸 Bronx, New York, United States